UPTRAVI
NDC 66215-718, Selexipag, injection, powder, for solution, from Actelion Pharmaceuticals US, Inc..
- Product NDC
- 66215-718
- Status
- Listed
- Labeler
- Actelion Pharmaceuticals US, Inc.
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214275
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66215-718 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SELEXIPAG1800 ug/10mL
Pharmacologic classes
Prostacyclin Receptor Agonist [EPC]; Prostacyclin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66215-718-01 | 66215071801 | 1 VIAL, SINGLE-DOSE in 1 CARTON (66215-718-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a7a23b87-f892-4e2c-8e2e-ebf841220f90
Use it
Look up 66215-718 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66215-718 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66215-718. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.